Literature DB >> 19776413

The delayed-start study design.

Ralph B D'Agostino1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19776413     DOI： 10.1056/NEJMsm0904209

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  39 in total

1.  Does rasagiline have a disease-modifying effect on Parkinson's disease?

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

Review 2.  Clinical pharmacology = disease progression + drug action.

Authors:  Nick Holford
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

Review 3.  Disease modification in Parkinson's disease.

Authors:  Claire Henchcliffe; W Lawrence Severt
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

4.  Effects of a formal exercise program on Parkinson's disease: a pilot study using a delayed start design.

Authors:  A Park; D Zid; J Russell; A Malone; A Rendon; A Wehr; X Li
Journal:  Parkinsonism Relat Disord       Date:  2013-10-15       Impact factor: 4.891

Review 5.  Randomized phase II trials: a long-term investment with promising returns.

Authors:  Manish R Sharma; Walter M Stadler; Mark J Ratain
Journal:  J Natl Cancer Inst       Date:  2011-06-27       Impact factor: 13.506

Review 6.  Bariatric surgery: a systematic review of the clinical and economic evidence.

Authors:  Raj Padwal; Scott Klarenbach; Natasha Wiebe; Maureen Hazel; Daniel Birch; Shahzeer Karmali; Arya M Sharma; Braden Manns; Marcello Tonelli
Journal:  J Gen Intern Med       Date:  2011-05-03       Impact factor: 5.128

7.  Parkinson disease: ADAGIO trial hints that rasagiline slows disease progression.

Authors:  Cristina Sampaio; Joaquim J Ferreira
Journal:  Nat Rev Neurol       Date:  2010-03       Impact factor: 42.937

8.  Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future.

Authors:  Anthony E Lang
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

Review 9.  Improving Memory and Cognition in Individuals with Down Syndrome.

Authors:  Michael S Rafii
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

Review 10.  Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?

Authors:  J Eric Ahlskog; Ryan J Uitti
Journal:  Neurology       Date:  2010-04-06       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.